The PNC Financial Services Group, Inc. (PNC)

PNC closed at $232.00 with a 67% position inside its 52-week range, having run up 25.53% over the past year while sliding 9.18% over three months. The stock is trading just above its 200-day moving average of $229.32, and the most recent sign of strength came from the analyst side: UBS and Oppenheimer both reiterated their ratings on November 2, 2026. For investors, the key question is whether the price can hold above the cluster of averages near $228 to $229 while the company keeps beating earnings estimates. The stock trades at a trailing P/E of 12.36, a discount to the sector median of 16.5, and it has beaten EPS estimates in all seven of the most recent reports. Revenue growth of 10.90% in the latest quarter, year on year, trailed the sector median of 11.7%.

The strongest signal in the figures comes from the analyst community and the earnings record. Of 23 analysts with a current rating, 16 rate the stock buy or strong buy, 7 hold it and none sell it. That is up from 15 buy ratings out of 22 three months ago. On November 2, 2026, UBS kept its Buy rating and Oppenheimer kept its Outperform rating, and on October 30, 2026, JP Morgan kept its Overweight rating. Wolfe Research took over coverage at Peer Perform on October 27, 2026.

PNC has beaten the EPS estimate in all seven of the most recent reports. The October 15, 2026 report delivered $4.97 against an estimate of $4.89, a beat of 1.64%, and the shares rose 1.14% in the first session after it. The January 16, 2026 report was the largest beat of the last four, at $4.88 against $4.21, or 15.91%, and the shares fell 0.99% the next session. Beats have not always lifted the price: three of the seven beats were followed by a lower share price in the first session, so investors have not treated a beat as an automatic catalyst.

At a trailing P/E of 12.36, the stock sits 25.1% below the sector median of 16.5, and its price-to-sales ratio of 3.69 is 2.9% below the sector median of 3.8. The trailing dividend yield is 3.19%, paying $7.40 a share a year. The discount is not explained by margins, since the net profit margin is 30.2% and the operating margin is 38.98%. Return on equity of 13.10% is below the sector median of 13.8%, and revenue growth of 10.90% trails the 11.7% median, which is the likely reason the market has not priced the stock at the sector multiple.

Over the last 18 months, insiders sold $29.9M of stock across 19 sales and bought $8K across two open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market buying.

The base case is that PNC holds above its moving averages and grinds toward the middle of its range, provided earnings keep meeting or beating estimates and revenue growth keeps pace with the 14.2% expected for this fiscal year. Analysts' estimates for 2026 EPS of $18.96 and for 2027 of $21.35 support that path, and the median 12-month price target of $265.00 sits 14.2% above the price, with a range from $240.00 to $285.00. Analysts are overwhelmingly positive, with 16 of 23 rating the stock buy or strong buy and none at sell. Conditions that would improve the picture are a sustained close above the 52-week high of $258.96 and a rise in revenue growth above the sector median. Conditions that would weaken it are a loss of the $229.32 200-day average, which would bring the $177.08 52-week low into view as a distant reference, or a quarter in which EPS falls short of estimates after seven straight beats. The simulation of past volatility suggests a typical daily move of about 1.22%, so the path will likely be gradual rather than abrupt.

Support sits first at $229.32, the 200-day simple moving average, which the price cleared by a narrow margin. Below it lies the 50-day simple moving average at $228.13, then the 20-day exponential moving average at $227.80; these three sit close together, so they act as one zone rather than separate barriers. The 52-week low of $177.08 is the deeper floor. Resistance begins at the 52-week high of $258.96, the nearest level above the price and the level a rise would meet first. The analysts' median 12-month target of $265.00 lies just above that high and is a forecast, not a technical level.